Quick Links

 Selected Publications

Xie J, Ma Y, Horne DA. Asymmetric Synthesis of the C(7)-C(23) Fragment of Iriomoteolide-1a.  Org Lett 2009;11:5082-5084.

Ma Y, Yakushijin K, Miyake F, Horne D. A concise synthesis of inolic enamides: coscinamide A, coscinamide B and igzamide. Tetraheron Lett. 2009;50:4343-4345.

Xie J, Horne D. Stereoselective synthesis of iriomotellide-1a hemiketal core. Tetrahedrom Lett.  2009;50:4485-4487.

Tonsiengsom S, Miyake FY, Yakushijin K, Horne DA. Reduction of 2,5-Bis(3'-indolyl)pyrazines to 2,5-bis(3'-indolyl)piperazines: Synthesis of bisindolylpiperazine marine alkaloids dragmacidin A, B, and C.Synthesis 2006;49-54.

Miyake FY, Yakushijin K, Horne DA.  Biomimetic synthesis of grossularines-1. Angew Chem Int Ed 2005;44:3280-3284.

Castedo M, Perfettini JL, Roumier T, Valent A, Raslova H, Yakushijin K, Horne D, Feunteun J, Lenoir G, Medema R, Vainchenker W, Kroemer G. Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy.Oncogene 2004;23:4362-70.

Castedo M, Perfettini JL, Roumier T, Yakushijin K, Horne D, Medema R, Kroemer G.  The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe.  Oncogene 2004;23:4353-56.

Shimizu H, Shimizu K, Kubodera N, Yakushijin K, Horne DA. Regioselective cleavage of trisubstituted epoxy-linkage using lithium trialkylborohydride reagents: a new route to the key intermediate of maxacalcitol.  Heterocycles 2004;63:1335-43.

Shimizu H, Shimizu K, Kubodera N, Yakushijin K, Horne DA. Efficient modification of steroid 20s-hydroxy functionality for industrial preparation of 1a, 25-dihydroxy-22-oxavitamin D3, maxacalcitol. Tetrahedron Lett. 2004;45:1347-50.

Miyake FY, Yakushijin K, Horne DA. Preparation and synthetic applications of 2-halotyptamines:  Synthesis of elacomine and isoelacomine. Org Lett 2004;6:711-13.

Miyake FY, Yakushijin K, Horne DA. A concise synthesis of spirotryprostatin A. Org Lett 2004;6:4249-51.

Miyake FY, Yakushijin K, Horne DA.  Preparation and synthetic applications of 2-halotryptophan methyl esters: Synthesis of spirotryprostatin B.  Angew Chem Intl Ed 2004;43:5357-60; Angew Chem 2004;5471-74.

Miyake FY, Yakushijin K, Horne DA. Synthesis of marine sponge bisindole alkaloids dihydrohamacanthins. Org Lett 2002;4:941-43.

Wiese KJ, Yakushijin K, Horne DA. Synthesis of dibromophakellstatin and dibromoisophakellin. Tetrahedron Lett 2002;43:5135-36.

Barrios Sosa AC, Yakushijin K., Horne DA. Synthesis of axinohydantoins. J Org Chem 2002;67:4498-500.

Miyake FY, Yakushijin K, Horne DA. A concise synthesis of topsentin A and nortosentins B and D. Org Lett 2000;2:2121-23.

Miyake FY, Yakushijin K, Horne DA. A facile synthesis of dragmacidin B and 2,5-bis(6’-bromo-3’-indolyl)piperazine. Org Lett 2000;2:3185-87.

Barrios Sosa AC, Yakushijin K, Horne DA. A practical synthesis of (Z)-debromohymenialdisine.  J Org Chem 2000;65:610-11.

Barrios Sosa AC, Yakushijin K, Horne DA. “Controlling C-C and N-C cyclizations of 2-pyrrolecarboxamidoacetals. Synthesis of longamide and structure revision of homolongamide. Tetrahedron Lett 2000;40:4295-98.

Barrios Sosa AC, Yakushijin K, Horne DA. Synthesis of slagenin A, B, and C. Org Lett 2000;2:3443-44.

This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 11/09.

 

 Search

Go!
Advanced Search Options
News & Publications Search
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S.News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.